The ADA 2025 oral presentation (abstract 143-OR) was titled "Reduces Body Weight without Muscle Loss," and that effect is attributed to the compound's IGF-1 pathway
Animal models suggest that BPC 157 may support recovery by influencing tissue repair pathways involved in cellular migration, wound closure, and functional recovery
Keeping up with demand might be the bigger issue
The amino terminus is situated on the extracellular side, while the carboxyl terminus is on the intracellular side
When dietary changes and lifestyle modifications plateau, GLP-1 medications present an evidence-based pharmacological option to extend long-term weight loss success without requiring revision procedures
Common side effects include gastrointestinal issues, which lead to about 10% of patients discontinuing use, as well as risks like hypotension, pancreatitis, and the progression of diabetic retinopathy